Cochlear | COH - Loan Capital


Cochlear reported AUD200M in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Ansell USD 751.6M 113.1M Dec/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Cochlear AUD 200M 6.5M Dec/2025
CSL USD 10.42B 273M Dec/2025
Fisher Paykel Healthcare NZD 113.3M 50.7M Jun/2026
Healius AUD 1.22B 103M Dec/2024
Integral Diagnostics AUD 341.63M 1.98M Jun/2024
Mayne Pharma AUD 2.66M 153K Jun/2025
Mesoblast USD 113.71M 47.68M Jun/2026
Monash IVF AUD 186.73M 16.17M Dec/2025
Nanosonics AUD 3.21M 1.06M Dec/2025
Polynovo AUD 15.39M 663K Dec/2025
Ramsay Health Care AUD 11.2B 5.74B Dec/2025
Regis Healthcare AUD 3.24M 435K Dec/2025
ResMed USD 404.17M 248K Mar/2026
Sigma Healthcare AUD 1.88B 1.75B Dec/2025
Somnomed AUD 20.94M 257.07K Jun/2023
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Telix Pharmaceuticals AUD 564.44M 115.99M Jun/2026